Jennifer Danielle Bleck, PA
Physician Assistant · Santa Rosa
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 7 years
- Loma Linda University School of Medicine, 2019
Offices
2 locations · Redwood Fam Dermatology Medical Associates - A Medical Corporation · 18 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Jennifer Danielle Bleck’s office to ask if they take your plan before you enroll.
Original Medicare doctor bills
$171,483
Medicare paid this office $171,483 for 1,102 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 544 | $36,119 | $56 |
| Destruction of precancer skin growth, 1 growth | 435 | $19,176 | $38 |
| Biopsy of related skin growth, first growth | 265 | $19,008 | $65 |
| Return visit (30+ min) | 165 | $16,300 | $82 |
| Destruction of skin growth, 1-14 growths | 165 | $13,479 | $74 |
See all 21 services
| Short return visit (20+ min) | 544 | $36,119 | $56 |
| Destruction of precancer skin growth, 1 growth | 435 | $19,176 | $38 |
| Biopsy of related skin growth, first growth | 265 | $19,008 | $65 |
| Return visit (30+ min) | 165 | $16,300 | $82 |
| Destruction of skin growth, 1-14 growths | 165 | $13,479 | $74 |
| Destruction of precancer skin growth, 2-14 growths | 347 | $10,547 | $5 |
| New patient visit (30+ min) | 155 | $9,349 | $60 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 16 | $7,367 | None |
| Destruction of precancer skin growth, 15 or more growths | 52 | $6,895 | $113 |
| New patient visit (45+ min) | 40 | $4,219 | $105 |
| Short return visit | 102 | $3,970 | $36 |
| Biopsy of related skin growth, each additional growth | 64 | $3,025 | $37 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 13 | $2,943 | $210 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | 12 | $2,401 | $200 |
| Application of light to destroy precancer skin growth | 16 | $2,018 | $101 |
| Punch biopsy, first skin growth | 25 | $2,001 | $80 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 18 | $1,663 | $92 |
| Biopsy of ear | 21 | $1,285 | $56 |
| New patient visit (15+ min) | 20 | $832 | $42 |
| Injection into skin growth, 1-7 growths | 18 | $613 | $29 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 23 | $23 | None |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 68 | More than 90% of doctors who do this |
| Removal of skin lesions | 1387 | More than 96% of doctors who do this |
| Skin biopsy | 449 | More than 95% of doctors who do this |
Procedures year by year
| Procedure | 2023 | 2024 |
|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 1,268 | 2,162 |
| Destruction of precancer skin growth, 1 growth | 315 | 504 |
| Biopsy of related skin growth, first growth | 180 | 291 |
| Destruction of skin growth, 1-14 growths | 132 | 183 |
| Biopsy of related skin growth, each additional growth | 49 | 82 |
| Destruction of precancer skin growth, 15 or more growths | 42 | 61 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
1,102 Original Medicare patients in 2024. Average age 74 · Under 65 5% · 85 and older 12% · Women 57% · Also on Medicaid 20% · Health risk score 0.98. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 56% · Coronary heart disease 19% · Depression 18% · Diabetes 17% · Atrial fibrillation 16% · Chronic kidney disease 15% · Cancer 15% · Heart failure 9% · COPD 8% · Stroke 5% · Dementia 3%.
The office billed $533,330, Medicare allowed $244,786 and paid $171,483; for 4,903 services of 47 kinds; $7,399 of it was for drugs given in the office and $164,084 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,102 | 4,903 | 74 | 0.98 | $533,330 | $171,483 |
| 2023 | 771 | 3,169 | 74 | 0.96 | $359,928 | $121,020 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 16 services
| Short return visit (20+ min) | 311 | $21,706 | $59 |
| Return visit (30+ min) | 149 | $15,082 | $82 |
| New patient visit (30+ min) | 199 | $13,261 | $67 |
| Biopsy of related skin growth, first growth | 169 | $12,689 | $70 |
| Destruction of precancer skin growth, 1 growth | 276 | $12,304 | $39 |
| Destruction of skin growth, 1-14 growths | 112 | $10,884 | $82 |
| New patient visit (45+ min) | 64 | $6,800 | $106 |
| Destruction of precancer skin growth, 2-14 growths | 225 | $6,204 | $5 |
| Destruction of precancer skin growth, 15 or more growths | 41 | $5,365 | $128 |
| Short return visit | 74 | $3,316 | $40 |
| Biopsy of related skin growth, each additional growth | 37 | $1,886 | $38 |
| New patient visit (15+ min) | 35 | $1,593 | $46 |
| Punch biopsy, first skin growth | 15 | $1,368 | $91 |
| Biopsy of ear | 14 | $853 | $57 |
| Injection into skin growth, 1-7 growths | 18 | $730 | $28 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 19 | $22 | None |
Medicaid work
$4,292 in 2024
Medicaid paid $4,292 for 94 billed services this clinician did in 2024, up to 20 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 66 | $3,773 |
| Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); single lesion | 12 | $285 |
| Short return visit (20+ min) | 16 | $234 |
| 2024 | 94 | 3 | 20 | $4,292 |
| 2023 | 12 | 1 | 12 | $69 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 12 | $69 |
Drugs they prescribed that Part D paid
$776,278
Pharmacies billed $776,278 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 919) in 2024. At or below the middle of the specialty; the typical physician assistant clinician is at 1%.
809 generic and 110 brand-name prescriptions · $776,278 in drug cost · 88 antibiotic prescriptions to 50 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Skyrizi | 16 | $332,778 | $20,799 |
| Dupixent | 28 | $106,653 | $3,809 |
| Dupixent | 18 | $68,851 | $3,825 |
| Clobetasol Propionate | 69 | $4,277 | $62 |
| Fluocinonide | 53 | $2,156 | $41 |
See all 20 drugs
| Skyrizi | 16 | $332,778 | $20,799 |
| Dupixent | 28 | $106,653 | $3,809 |
| Dupixent | 18 | $68,851 | $3,825 |
| Clobetasol Propionate | 69 | $4,277 | $62 |
| Fluocinonide | 53 | $2,156 | $41 |
| Metronidazole | 42 | $2,146 | $51 |
| Tacrolimus | 17 | $1,483 | $87 |
| Fluocinolone Acetonide | 30 | $1,477 | $49 |
| Ketoconazole | 99 | $1,286 | $13 |
| Triamcinolone Acetonide | 157 | $1,241 | $8 |
| Fluorouracil | 13 | $934 | $72 |
| Doxycycline Hyclate | 46 | $737 | $16 |
| Fluocinolone Acetonide | 11 | $579 | $53 |
| Minoxidil | 50 | $425 | $8 |
| Fluocinolone Acetonide Oil | 13 | $394 | $30 |
| Ciclopirox | 12 | $297 | $25 |
| Hydrocortisone | 57 | $249 | $4 |
| Cephalexin | 34 | $223 | $7 |
| Clotrimazole | 12 | $195 | $16 |
| Hydroxyzine | 16 | $166 | $10 |
Year by year
| 2024 | 919 | 383 | 0% (0) | 12% | $776,278 |
| 2023 | 475 | 247 | 0% (0) | 7% | $210,630 |
| 2022 | 191 | 84 | 0% (0) | None | $9,057 |
| 2021 | 149 | 65 | 0% (0) | None | $5,401 |
| 2020 | 76 | 38 | 0% (0) | None | $1,936 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Clobetasol Propionate | 43 | $5,254 | $122 |
| Metronidazole | 29 | $2,314 | $80 |
| Ketoconazole | 63 | $1,635 | $26 |
| Fluocinolone Acetonide | 19 | $1,547 | $81 |
| Fluorouracil | 11 | $1,040 | $95 |
| Triamcinolone Acetonide | 90 | $982 | $11 |
| Fluocinonide | 12 | $554 | $46 |
| Cephalexin | 18 | $318 | $18 |
| Hydrocortisone | 42 | $228 | $5 |
| Mupirocin | 13 | $110 | $8 |
2022: 5 drugs
| Fluorouracil | 19 | $1,319 | $69 |
| Clobetasol Propionate | 14 | $770 | $55 |
| Ciclopirox | 12 | $486 | $41 |
| Ketoconazole | 33 | $378 | $11 |
| Triamcinolone Acetonide | 13 | $65 | $5 |
2021: 4 drugs
| Fluorouracil | 24 | $1,252 | $52 |
| Clobetasol Propionate | 15 | $1,104 | $74 |
| Ketoconazole | 25 | $489 | $20 |
| Triamcinolone Acetonide | 14 | $95 | $7 |
2020: 1 drug
| Ketoconazole | 12 | $389 | $32 |
Money from drug and device companies
$2,428 in 2025
| 2025 | 16 | 115 | None | $2,428 |
| 2024 | 19 | 120 | None | $2,990 |
| 2023 | 10 | 42 | None | $1,125 |
| 2022 | 2 | 3 | None | $277 |
| 2021 | 1 | 2 | None | $47 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Biotech | Tremfya | $392 | 18 payments
|
| Arcutis Biotherapeutics | Zoryve | $342 | 13 payments
|
| Abbvie | Skyrizi | $341 | 20 payments
|
| Ucb | Bimzelx | $228 | 11 payments
|
| Pfizer | Cibinqo | $197 | 12 payments
|
| Novartis Pharmaceuticals | Cosentyx | $174 | 9 payments
|
See all 115 published payments
| Arcutis Biotherapeutics | Meals · 2025-12-17 | Zoryve | $13 |
| Abbvie | Meals · 2025-12-16 | Rinvoq | $22 |
| LEO Pharma | Meals · 2025-12-15 | Adbry | $24 |
| Abbvie | Meals · 2025-11-26 | Skyrizi | $7 |
| Sun Pharmaceutical Industries | Meals · 2025-11-14 | Ilumya | $22 |
| Ucb | Meals · 2025-11-13 | Bimzelx | $25 |
| Incyte | Meals · 2025-11-13 | Opzelura | $22 |
| Arcutis Biotherapeutics | Meals · 2025-11-13 | Zoryve | $16 |
| Arcutis Biotherapeutics | Meals · 2025-11-13 | Zoryve | $12 |
| Arcutis Biotherapeutics | Meals · 2025-11-13 | Zoryve | $10 |
| Arcutis Biotherapeutics | Meals · 2025-11-04 | Zoryve | $14 |
| Ucb | Meals · 2025-10-31 | Bimzelx | $26 |
| Janssen Biotech | Meals · 2025-10-26 | Tremfya | $3 |
| Incyte | Meals · 2025-10-21 | Opzelura | $23 |
| Abbvie | Meals · 2025-10-15 | Skyrizi | $23 |
| LEO Pharma | Meals · 2025-10-10 | Adbry | $21 |
| Janssen Biotech | Meals · 2025-10-03 | Tremfya | $24 |
| Janssen Biotech | Meals · 2025-10-01 | Tremfya | $25 |
| Janssen Biotech | Meals · 2025-10-01 | Tremfya | $2 |
| Incyte | Meals · 2025-10-01 | Opzelura | $15 |
| Arcutis Biotherapeutics | Meals · 2025-09-30 | Zoryve | $17 |
| Lilly USA | Meals · 2025-09-23 | Taltz | $30 |
| Pfizer | Meals · 2025-09-22 | Cibinqo | $21 |
| Arcutis Biotherapeutics | Meals · 2025-09-10 | Zoryve | $15 |
| Janssen Biotech | Meals · 2025-09-09 | Tremfya | $26 |
| Abbvie | Meals · 2025-09-03 | Rinvoq | $29 |
| Genzyme | Meals · 2025-09-03 | Dupixent | $22 |
| Galderma Laboratories L.P. | Meals · 2025-08-27 | Nemluvio | $25 |
| Incyte | Meals · 2025-08-20 | Opzelura | $30 |
| Ucb | Meals · 2025-08-15 | Bimzelx | $15 |
| Ucb | Meals · 2025-08-15 | Bimzelx | $15 |
| Lilly USA | Meals · 2025-08-12 | Taltz | $25 |
| Abbvie | Meals · 2025-08-05 | Rinvoq | $15 |
| Arcutis Biotherapeutics | Meals · 2025-08-05 | Zoryve | $28 |
| Galderma Laboratories L.P. | Meals · 2025-07-30 | Nemluvio | $28 |
| LEO Pharma | Meals · 2025-07-29 | Adbry | $20 |
| Abbvie | Meals · 2025-07-25 | Skyrizi | $7 |
| Ucb | Meals · 2025-07-24 | Bimzelx | $15 |
| Pfizer | Meals · 2025-07-18 | Cibinqo | $26 |
| Abbvie | Meals · 2025-07-16 | Rinvoq | $11 |
| Ucb | Meals · 2025-07-11 | Bimzelx | $25 |
| Pfizer | Meals · 2025-07-11 | Cibinqo | $19 |
| Janssen Biotech | Meals · 2025-07-08 | Tremfya | $24 |
| Janssen Biotech | Meals · 2025-07-02 | Tremfya | $23 |
| Pfizer | Meals · 2025-07-02 | Cibinqo | $11 |
| Ucb | Meals · 2025-06-27 | Bimzelx | $19 |
| Ucb | Meals · 2025-06-27 | Bimzelx | $26 |
| Pfizer | Meals · 2025-06-24 | Cibinqo | $25 |
| Arcutis Biotherapeutics | Meals · 2025-06-24 | Zoryve | $23 |
| Abbvie | Meals · 2025-06-17 | Skyrizi | $20 |
| Incyte | Meals · 2025-06-13 | Opzelura | $24 |
| Lilly USA | Meals · 2025-06-11 | Ebglyss | $30 |
| Novartis Pharmaceuticals | Meals · 2025-06-11 | None | $23 |
| Pfizer | Meals · 2025-06-06 | Cibinqo | $7 |
| Janssen Biotech | Meals · 2025-06-05 | Tremfya | $28 |
| Galderma Laboratories L.P. | Meals · 2025-06-04 | Nemluvio | $22 |
| Pfizer | Meals · 2025-05-30 | Cibinqo | $14 |
| Genzyme | Meals · 2025-05-28 | Dupixent | $21 |
| Pfizer | Meals · 2025-05-24 | Cibinqo | $15 |
| Abbvie | Meals · 2025-05-21 | Skyrizi | $19 |
| Abbvie | Meals · 2025-05-17 | Rinvoq | $7 |
| Abbvie | Meals · 2025-05-17 | Rinvoq | $4 |
| Abbvie | Meals · 2025-05-17 | Rinvoq | $7 |
| Genzyme | Meals · 2025-05-15 | Dupixent | $38 |
| Galderma Laboratories L.P. | Meals · 2025-05-15 | Nemluvio | $17 |
| Janssen Biotech | Meals · 2025-05-13 | Tremfya | $26 |
| Ucb | Meals · 2025-05-09 | Bimzelx | $14 |
| Novartis Pharmaceuticals | Meals · 2025-05-07 | Cosentyx | $30 |
| Janssen Biotech | Meals · 2025-05-06 | Tremfya | $7 |
| Janssen Biotech | Education · 2025-05-06 | Tremfya | $72 |
| Amgen | Meals · 2025-05-06 | Otezla | $20 |
| Pfizer | Meals · 2025-05-01 | Cibinqo | $14 |
| Abbvie | Meals · 2025-04-29 | Skyrizi | $19 |
| Arcutis Biotherapeutics | Meals · 2025-04-29 | Zoryve | $13 |
| LEO Pharma | Meals · 2025-04-25 | Adbry | $24 |
| Novartis Pharmaceuticals | Meals · 2025-04-23 | None | $77 |
| Almirall | Meals · 2025-04-22 | Klisyri | $17 |
| Janssen Biotech | Meals · 2025-04-16 | Tremfya | $23 |
| Regeneron Healthcare Solutions | Meals · 2025-04-16 | Dupixent | $24 |
| Galderma Laboratories L.P. | Meals · 2025-04-15 | Nemluvio | $19 |
| Pfizer | Meals · 2025-04-11 | Cibinqo | $18 |
| Abbvie | Meals · 2025-04-04 | Rinvoq | $12 |
| LEO Pharma | Meals · 2025-04-04 | Adbry | $20 |
| Ucb | Meals · 2025-03-28 | Bimzelx | $29 |
| Galderma Laboratories L.P. | Meals · 2025-03-26 | Nemluvio | $19 |
| Arcutis Biotherapeutics | Meals · 2025-03-25 | Zoryve | $12 |
| Abbvie | Meals · 2025-03-21 | Rinvoq | $22 |
| Abbvie | Meals · 2025-03-19 | Skyrizi | $23 |
| Janssen Biotech | Meals · 2025-03-18 | Tremfya | $12 |
| Lilly USA | Meals · 2025-03-18 | Taltz | $24 |
| Janssen Biotech | Meals · 2025-03-11 | Tremfya | $20 |
| Pfizer | Meals · 2025-03-07 | Cibinqo | $17 |
| Ucb | Meals · 2025-03-05 | Bimzelx | $18 |
| Organon | Meals · 2025-02-28 | Vtama | $29 |
| Abbvie | Meals · 2025-02-26 | Skyrizi | $21 |
| Novartis Pharmaceuticals | Meals · 2025-02-21 | Cosentyx | $5 |
| Novartis Pharmaceuticals | Meals · 2025-02-21 | Cosentyx | $8 |
| Abbvie | Meals · 2025-02-21 | Skyrizi | $19 |
| Arcutis Biotherapeutics | Meals · 2025-02-21 | Zoryve | $146 |
| Novartis Pharmaceuticals | Meals · 2025-02-20 | Cosentyx | $2 |
| Novartis Pharmaceuticals | Meals · 2025-02-20 | Cosentyx | $9 |
| Novartis Pharmaceuticals | Meals · 2025-02-20 | Cosentyx | $5 |
| Pfizer | Meals · 2025-02-14 | Cibinqo | $10 |
| Arcutis Biotherapeutics | Meals · 2025-02-12 | Zoryve | $22 |
| Janssen Biotech | Meals · 2025-02-11 | Tremfya | $24 |
| LEO Pharma | Meals · 2025-02-07 | Adbry | $24 |
| Janssen Biotech | Meals · 2025-02-05 | Tremfya | $18 |
| Genzyme | Meals · 2025-02-04 | Dupixent | $24 |
| Janssen Biotech | Meals · 2025-01-28 | Tremfya | $14 |
| Novartis Pharmaceuticals | Meals · 2025-01-23 | Cosentyx | $13 |
| Abbvie | Meals · 2025-01-22 | Skyrizi | $30 |
| Lilly USA | Meals · 2025-01-21 | Taltz | $33 |
| Regeneron Healthcare Solutions | Meals · 2025-01-15 | Dupixent | $19 |
| Janssen Biotech | Meals · 2025-01-14 | Tremfya | $22 |
| Abbvie | Meals · 2025-01-09 | Skyrizi | $23 |
See earlier years (2024, 2023, 2022, 2021)
2024: $2,990
| Abbvie | Skyrizi | $629 | 29 payments
|
| Janssen Biotech | Tremfya | $479 | 16 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $312 | 14 payments
|
| Regeneron Healthcare Solutions | Dupixent | $290 | 8 payments
|
| Novartis Pharmaceuticals | Cosentyx | $286 | 16 payments
|
| Ucb | Bimzelx | $206 | 6 payments
|
| Incyte | Opzelura | $158 | 3 payments
|
| Arcutis Biotherapeutics | Zoryve | $111 | 5 payments
|
| Lilly USA | Taltz | $79 | 4 payments
|
| Sun Pharmaceutical Industries | Ilumya | $72 | 3 payments
|
| Amgen | Otezla | $61 | 2 payments
|
| Galderma Laboratories L.P. | None | $58 | 2 payments
|
| LEO Pharma | Adbry | $56 | 3 payments
|
| Ortho Dermatologics a division of Bausch Health US | Siliq | $48 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $47 | 2 payments
|
| Fresenius Kabi USA | Idacio | $42 | 2 payments
|
| Verrica Pharmaceuticals | Ycanth | $22 | 1 payment
|
| Genzyme | Dupixent | $19 | 1 payment
|
| Pfizer | Cibinqo | $16 | 1 payment
|
2023: $1,125
| Abbvie | Skyrizi | $492 | 21 payments
|
| Amgen | Otezla | $265 | 6 payments
|
| Lilly USA | Taltz | $90 | 3 payments
|
| Novartis Pharmaceuticals | Cosentyx | $87 | 3 payments
|
| Incyte | Opzelura | $68 | 3 payments
|
| Sun Pharmaceutical Industries | Winlevi | $39 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $27 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $19 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $19 | 1 payment
|
| Dermavant Sciences | Vtama | $18 | 1 payment
|
2022: $277
| Amgen | Otezla | $152 | 2 payments
|
| Sun Pharmaceutical Industries | Winlevi | $125 | 1 payment
|
2021: $47
| VYNE Pharmaceuticals | Zilxi | $47 | 2 payments
|
Professional record
- NPI
- 1326683350
- Trained
- Loma Linda University School of Medicine, 2019 · 7 years ago
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- 2725 Mendocino Ave, Santa Rosa, CA, 95403
- NPI first listed
- 2019-11-13
- NPI last updated
- 2023-01-06
- NPI record certified
- 2023-01-06
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 6571 W 84th St, Los Angeles, CA, 90045